Send to

Choose Destination
Biochem Biophys Rep. 2017 Mar 15;10:82-87. doi: 10.1016/j.bbrep.2017.03.004. eCollection 2017 Jul.

Differential usage of COX-1 and COX-2 in prostaglandin production by mast cells and basophils.

Author information

Department of Immune Regulation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Ono pharmaceutical co., ltd. Exploratory Research Laboratories, 3-1-1 Sakurai, Shimamoto-Cho, Mishima-Gun, Osaka 618-8585, Japan.


Basophils have been erroneously considered as minor relatives of mast cells, due to some phenotypic similarity between them. While recent studies have revealed non-redundant roles for basophils in various immune responses, basophil-derived effector molecules, including lipid mediators, remain poorly characterized, compared to mast cell-derived ones. Here we analyzed and compared eicosanoids produced by mouse basophils and mast cells when stimulated with IgE plus allergens. The production of 5-LOX metabolites such as LTB4 and 5-HETE was detected as early as 0.5 h post-stimulation in both cell types, even though their amounts were much smaller in basophils than in mast cells. In contrast, basophils and mast cells showed distinct time course in the production of COX metabolites, including PGD2, PGE2 and 11-HETE. Their production by mast cells was detected at both 0.5 and 6 h post-stimulation while that by basophils was detectable only at 6 h. Of note, mast cells showed 8-9 times higher levels of COX-1 than did basophils at the resting status. In contrast to unaltered COX-1 expression with or without stimulation, COX-2 expression was up-regulated in both cell types upon activation. Importantly, when activated, basophils expressed 4-5 times higher levels of COX-2 than did mast cells. In accordance with these findings, the late-phase production of the COX metabolites by basophils was completely ablated by COX-2 inhibitor whereas the early-phase production by mast cells was blocked by COX-1 but not COX-2 inhibitor. Thus, the production of COX metabolites is differentially regulated by COX-1 and COX-2 in basophils and mast cells.


BMBAs, bone marrow derived basophils; BMMCs, bone marrow derived mast cells; BW-A4C (PubChem CID: 6438354); Basophils; COX, cyclooxygenase; COX-2; Celecoxib (PubChem CID: 2662); Eicosanoids; HETE, hydroxyeicosatetraenoic acid; LC-MS/MS; LOX, lipoxygenase; LTA4, leukotriene A4; LTB4, leukotriene B4; LTC4, leukotriene C4; LTD4, leukotriene D4; Mast cells; OVA, Ovalbumin; PGD2, prostaglandin D2; PGE2, prostaglandin E2; Prostaglandins; SC-560 (PubChem CID: 4306515); TNP, 2,4,6-trinitrophenyl

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center